Bio-Techne appoints Will Geist President, Protein Sciences Segment, succeeding retiring Dave Eansor

BIO-TECHNE Corp

Geist, former COO of Quanterix and former VP/GM at Thermo Fisher, appointed effective Jan 3, 2022.
He succeeds N. David Eansor, who will retire and assist transition through Feb 2022.
Base salary $500,000; target cash bonus 85%; annual equity grants ~$1.8M; one-time RSU grant $1M.
Geist has over 20 years senior life science tools experience; CEO highlighted his experience running >$1B revenue businesses.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

N. David Eansor

President, Protein Sciences Segment

TECH · BIO-TECHNE Corp

Effective: 2022-02-28
Successor: William Alexander Geist
Filed: December 22, 2021, 6:59 PM ET

Mr. Geist succeeds N. David Eansor, who has announced his intention to retire.

Appointed

William Alexander Geist

President, Protein Sciences Segment

TECH · BIO-TECHNE Corp

Effective: 2022-01-03
Filed: December 22, 2021, 6:59 PM ET

On December 17, 2021, the Compensation Committee of the Board of Directors of Bio-Techne Corporation (the “Company”) appointed Mr. William Alexander Geist, age 52, as an executive officer of the Company in the position of President, Protein Sciences Segment, effective January 3, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.9

N. David Eansor departed as President, Protein Sciences Segment at BIO-TECHNE Corp.

Action: announced intention to retire
Role: President, Protein Sciences Segment

Exact text from the filing

Mr. Geist succeeds N. David Eansor, who has announced his intention to retire.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

William Alexander Geist was appointed as President, Protein Sciences Segment at BIO-TECHNE Corp.

Action: appointed
Role: President, Protein Sciences Segment

Exact text from the filing

On December 17, 2021, the Compensation Committee of the Board of Directors of Bio-Techne Corporation (the “Company”) appointed Mr. William Alexander Geist, age 52, as an executive officer of the Company in the position of President, Protein Sciences Segment, effective January 3, 2022.

View on SEC.gov

BIO-TECHNE Corp filing history →

Source: SEC EDGAR

accession 0001437749-21-029110

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.